• Copyrights
  • Privacy Policy
  • Terms
  • Shop
  • Fun Box
Biostandups | Connecting Science, Biotechnology & Healthcare
  • Home
  • Bio News
    • Bio Research
    • Bio Tech
    • Health, Food and Fitness
    • Agriculture
    • Public Health and Issues
    • Earth and Environment
    • Pharmacy
    • Women Health
  • Bio Woman
    • Face of the month
    • Raising talents
    • Voice of Women
    • WISE
  • Bio Business
    • Startup Guide
    • Entrepreneurship
  • JOB POSTINGS
    • Study at University
    • Organizations
    • Fellowships / Grants
    • Opportunities for Freshers
    • Awards/Prizes/Medals
  • Bio Protocols
    • Basic Protocols
    • Multiple Research Protocols
    • Video Protocols
    • Protocol Exchange
    • Thesis/Paper writing tools
  • Bio Events
  • About Us
    • Founding Team
    • Advisory Board
    • Partners
    • Editors
    • Contributors
    • Sponsors
    • Donate Us
    • Media Room
  • Contact us

Isoflavones, found in soy linked to longer life in Women with breast cancer

biostandadmin/07 Mar, 17/1648/0
Women Health
Credit @ safe bee

Isoflavones in food associated with reduced mortality for women with some breast cancers. Consuming foods rich in isoflavones, found in soy, is associated with reduced mortality in women with hormone-receptor-negative breast cancer and women not treated with endocrine therapy.

An epidemiological analysis of data from more than 6,000 American and Canadian women with breast cancer finds that post-diagnosis consumption of foods containing isoflavones—estrogen-like compounds primarily found in soy food—is associated with a 21 percent decrease in all-cause mortality. This decrease was seen only in women with hormone-receptor-negative tumors, and in women who were not treated with endocrine therapy such as tamoxifen.

The study, led by nutrition and cancer epidemiologist Fang Fang Zhang, M.D., Ph.D., from the Friedman School of Nutrition Science and Policy at Tufts University, was published March 6 in Cancer.

“At the population level, we see an association between isoflavone consumption and reduced risk of death in certain groups of women with breast cancer. Our results suggest, in specific circumstances, there may be a potential benefit to eating more soy foods as part of an overall healthy diet and lifestyle,” said Zhang, who is also the 2016-2017 Miriam E. Nelson Tisch Faculty Fellow at the Jonathan M. Tisch College of Civic Life and an adjunct scientist in nutritional epidemiology at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts.

“Since we only examined naturally occurring dietary isoflavone, we do not know the effect of isoflavone from supplements. We recommend that readers keep in mind that soy foods can potentially have an impact, but only as a component of an overall healthy diet,” she adds.

Isoflavones have been shown to slow the growth of breast cancer cells in laboratory studies, and epidemiological analyses in East Asian women with breast cancer found links between higher isoflavone intake and reduced mortality. However, other research has suggested that the estrogen-like effects of isoflavones may reduce the effectiveness of endocrine therapies used to treat breast cancer. Because of this double effect, it remains unknown whether isoflavone consumption should be encouraged or avoided by breast cancer patients.

In the current study, Zhang and her colleagues, including Esther John, Ph.D., senior cancer epidemiologist at the Cancer Prevention Institute of California, analyzed data on 6,235 American and Canadian breast cancer patients from the Breast Cancer Family Registry, a National Cancer Institute-funded program that has collected clinical and questionnaire data on enrolled participants and their families since 1995. Women were sorted into four quartile groups based on the amount of isoflavone they were estimated to have consumed, calculated from self-reported food frequency questionnaires. Mortality was examined after a median follow-up of 9.4 years.

The team found a 21 percent decrease in all-cause mortality among women in the highest quartile of intake, when compared to those in the lowest quartile. The association between isoflavone intake and reduced mortality was strongest in women with tumors that lacked estrogen and progesterone receptors. Women who did not receive endocrine therapy as a treatment for their breast cancer had a weaker, but still significant association. No associations were found for women with hormone-receptor-positive tumors and for women who received endocrine therapy.

While the study categorized women in the highest quartile as those who consumed 1.5 milligrams or more of isoflavone per day—equivalent to a few dried soybeans—the authors caution that individuals tend to underestimate their food intake when filling out questionnaires.

“The comparisons between high and low consumption in our study are valid, but our findings should not be interpreted as a prescription,” Zhang said. “However, based on our results, we do not see a detrimental effect of soy intake among women who were treated with endocrine therapy, which has been hypothesized to be a concern. Especially for women with hormone-receptor-negative breast cancer, soy food products may potentially have a beneficial effect and increase survival.”

The large size and diverse racial/ethnic makeup of the Breast Cancer Family Registry allowed the researchers to evaluate mortality risk across different subtypes of breast cancer and subgroups of patients, and adjust for confounding factors. However, the authors note that dietary isoflavone intake was correlated with socioeconomic and lifestyle factors, which may also play a role in lowering mortality. In particular, women who consumed higher levels of dietary isoflavone were more likely to be Asian Americans, young, physically active, more educated, not overweight, never smokers, and drink no alcohol. Although the team controlled for these factors in the analyses, the possibility of a partial confounding effect on the associations identified in the study cannot be ruled out.

“Whether lifestyle factors can improve survival after diagnosis is an important question for women diagnosed with hormone-receptor negative breast cancer, a more aggressive type of breast cancer. Our findings suggest that survival may be better in patients with a higher consumption of isoflavones from soy food,” John said.

Access the article published in Cancer journal HERE. The article was published at Tufts Now from Tufts University and written by Siobhan Gallagher.

Share
Trending

Is Rinsing Your Sinuses With Neti Pots Safe?

07 Mar, 17

“MeRck More than a Mother” in partnership...

07 Mar, 17

Related Posts

Bio NewsBio Tech

BACTERIA THAT EATS METAL, PROCESSES CARBON ACCIDENTALLY...

Bio NewsMicro BiologyPublic Health and Issues

Gut bacteria improve type 2 diabetes risk prediction

Health, Food and Fitness

Stem cell therapy: why we need to be suspicious about...

mm
biostandadmin

Leave a Reply Cancel reply

You must be logged in to post a comment.

View more jobs >>

Face of the month - February

A career in research is always challenging more so because the techniques and technologies are changing fast. One has to keep updated about the kind of work going on globally. Securing grants for your research is however the toughest challenge. Mentoring students and solving their problems also becomes quite challenging at times. - Dr. Charu Lata

Raising Talents

The moment he granted me a seat, the news spread like anything. The principal called Mr. Sahu and almost every person laughed at me. I was a very simple girl from middle-class family. Many unwanted suggestions poured in. But I think I was destined to be here. Days went by. At the end of every year, a mining student has to go for training in mines.

Most Viewed

Bio TechCareer

Best List of Biotech Internships in India

Agriculture

Evolution of Fruits and Vegetables –...

Most Commented

5 biologists to receive Elsevier Foundation...

06 Sep, 16

Career Talks on Biotechnology and Bioinformatics

04 Jan, 17

World Health/Biotech News

[wp-rss-aggregator limit="50" pagination="false"] View more >>

News By Category

  • Agriculture (73)
  • Bio News (146)
  • Bio Tech (103)
  • Career (40)
  • Earth and Environment (101)
  • Health, Food and Fitness (125)
  • Innovation & Technology (35)
  • Interview Series (11)
  • Micro Biology (1)
  • Pharmacy (98)
  • Public Health and Issues (144)
  • Startups (61)
  • Uncategorized (3)
  • Women Health (78)
  • Women in STEM (9)
  • Women safety (1)

Archives

  • July 2020
  • June 2020
  • November 2019
  • October 2019
  • July 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016

Recent Posts

BACTERIA THAT EATS METAL, PROCESSES CARBON...

22 Jul, 20

Gut bacteria improve type 2 diabetes risk...

06 Jul, 20

Stem cell therapy: why we need to be suspicious...

24 Jun, 20

PHAR-EAST 2020

The 3rd edition of Phar-East is happening in Singapore from 31 March to 1 April 2020. It is your chance to network with over 1,000 leading experts from across Asia and gain insights about the latest trends in the pharma and biotech industry.

  • Home
  • Our Mission
  • Privacy Policy
  • Advertise with us
  • Memberships